Mural Oncology plc Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
-194M
-207M
3M
24M
0M
-13M
-3M
3M
469M
0M
-0 %
0M
0M
0M
271M
271M
0M
-198M
-169M
-190M
2M
12M
0M
8M
-6M
6M
174M
0M
-0 %
0M
0M
174M
0M
0M
0M
-174M
-157M
-175M
1M
12M
0M
6M
-4M
4M
161M
0M
-0 %
0M
0M
161M
0M
0M
0M
-161M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
4Q2022
3Q2022
-43M
-60M
1M
15M
0M
1M
-1M
1M
315M
0M
-0 %
0M
0M
0M
271M
271M
0M
-44M
-50M
-51M
1M
3M
0M
-3M
-1M
1M
52M
0M
-0 %
0M
0M
52M
0M
0M
0M
-52M
0M
-48M
0M
0M
0M
0M
0M
0M
0M
0M
-0 %
0M
0M
0M
0M
0M
0M
0M
-38M
-49M
0M
3M
0M
7M
0M
0M
38M
0M
-0 %
0M
0M
38M
0M
0M
0M
-38M
-37M
-51M
0M
3M
0M
9M
-3M
3M
40M
0M
-0 %
0M
0M
40M
0M
0M
0M
-40M